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A new member of the family of G protein-coupled receptors has been isolated from a rat pituitary eDNA library by the polymerase chain reaction 
(PCR) using degenerate oligonucleotide primers. The corresponding protein s quence shows seven transmembrane domains and contains conserved 
regions of homology characteristic ofthe G protein-coupled class of receptors. The novel receptor mRNA is expressed in the brain, pituitary gland 
and testis, and has been localized by in situ hybridization in discrete regions of the brain. Expression f the receptor mRNA in Xenopus ooeytes 
and in transfected mammalian cells has not yet permitted identification of the corresponding ligand for this receptor. 
Polymerase chain reaction; G-protein receptor; Guanine nucleotide-binding re ulatory protein; Homology probing 
1. INTRODUCTION 
Recent developments in receptor biology have shown 
that a number of the receptors which interact with G 
protein signalling systems have sequence homologies 
and may be a part of a receptor superfamily [1]. Specific 
features of this family include seven stretches of 20-26 
residues of hydrophobic amino acids which include 
several invariant amino acids; potential N-linked gly- 
cosylation sites near the amino terminus and phospho- 
rylation sites near the carboxy terminus. The presence 
of partially conserved regions of sequence in the struc- 
tures of the receptor superfamily permits the use of 
homology screening in order to isolate novel receptors. 
We used PCR amplification of eDNA with degenerate 
oligonucleotide primers corresponding to conserved se- 
quences of various transmembrane domains and have 
isolated a novel receptor-coding clone from a rat pi- 
tuitary library. This paper describes the cloning, se- 
quence analysis and tissue expression and localization 
of this receptor molecule, one of a growing number of 
G protein- coupled receptors for which ligands have not 
yet been identified [2-5]. 
The G-protein coupled receptor cDNA sequence reported here has been 
assigned the accession umber X61496 by the EMBL Data Library. 
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2. MATERIALS AND METHODS 
2.1. Rat pituitary cDNA librao, screens 
Library screens of a size-selected lambda ZAP I1 eDNA library (107 
independent clones) prepared from rat pituitary tissue were performed 
using standard techniques [6]. Bluescript plasmids were rescued from 
plaque purified clones by M I3 excision (Stratagene). 
2.2. Oligonucleotide~ 
Oligonucleotides were synthesized on an Applied Biosystems PCR- 
Mate 391A DNA synthesizer according to the manufacturer's instruc- 
tions. Primer TM3 was based on conserved sequences found in the
third transmembrane region [2]; (TM3, 5'GTCGACCTGTG(TC)G 
(TC)(GC)AT(TC) GCIIT(TG)GA (TC)(AC) G(GC)TAT3'), primer 
TM6 on those in the sixth transmembrane r gion; (TM6, 
5"AAGCTTA(TG)G(AT)AG(AT)AG GGCAGCCAG CAGAI 
(GC)(AG)(TC)AAA3'). Primers for analytical PCR were: (matching 
at 869) 5'TGTAAGAT TGTGATGAGGCACG3' (matching at 1223) 
5' GAGAACGCTGCTACACATCG 3" 
2.3. PCR amplification of pituitary, cDNA attd tissue RN,4s 
eDNA reverse transcribed from rat tissue mRNA was submitted to 
30 cycles of PCR with Taq polymerase [7]. Cycle conditions were 1.5 
rain at 93°C, 1 rain at 50°C and 2 rain at 72°C. PCR was carried out 
in the presence of [32P]dCTP (2 pCi) for the tissue distribution exper- 
iment and the reaction products electrophoresed on a sequencing gel
with size standards. Positive and negative controls were run in parallel 
to check amplification f known sequences and to detect possible 
template contamination. 
2.4. DNA sequenc#tg attd comput#tg 
DNA sequencing was carried out using Sequenase (USB) and anal- 
ysis was provided by means of a program (GeneJockey) running on 
Apple Macintosh microcomputers (P.L. Taylor, Biosoft, Cambridge, 
UK). General database searching and access to the AMT digital array 
processor (DAP) was obtained via SEQNET (SERC Daresbury Labo- 
ratory). 
2.5. hl situ h),bridi=atiot~ 
Riboprobe preparation from R334 eDNA and in situ hybridization 
were carried out according to previously described methods [8]. 
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I CTGCGACCTGCGGGGGCGCGCGCAGCCTCGTGGGGT 
37 TCTcG~GGATGG~G~CGGG~GGGGAG~G~CAGGGcGGAGAG~cGGGcGC~AGCGA~G~AGCT~Ac~TG~CGcGGGcGCcACCACG 
124 GACGT~CCACG~GGGTGGc~CTc~cTATTc~GcAGcAc~GAAGGAGcCcC~C~T~GGT~TGG~CGTG~AAGAGGA~AGGGGTTAAA 
V 
MeH Ash Glu Asp Pro Lys val Ash Leu Set oly Leu PEO AEg Asp Cys Ile GIu Ala Gly Thr Pro 22 
211 ATG AAC GAA GAC CCG AAG GTC AAT TTA AGC GGG CTG CCT COG GAC TGT ATA GAA OCT GGT ACT CCG 
V 
Glu Ash Ile SeE Ala A la  Val Pro Sot Gln Gly Set Val Val Glu Set Glu Pro GIu Leu Val Val 44 
279 GAG AAC ATC TCA GCC OCT GTC CCC TCC CAG GGC TCT GTT GTG GAG TCA GAA CCC GAG CTC GTT GTC 
I 
ASh Pro Trp Asp Ile Val Leu Cys Set Set Giy Thr  Leu ~i.o Cys Cvs GIu Ash Ala Val val Val 66 
344 AAC CCC TGG GAC ATT GTC TTG TGC AGC TCA GGA ACC CTC ATe TGC TGT GAA AAT GCC GTC GTG GTC 
Lou Ii~ Ile Phe His Set Pro Set Leu Arg Ala Pro M@H Phe L~u Leu Ile Glv Ser Leu Ala Leu 88 
410 CTT ATe ATC TTC CAC AGC CCC AGC CTG CGA GCA CCC ATG TTC CTG CTG ATA GGC AGC CTG OCT CTT 
H 
ALa Asp Leu Leu A1a GI7 Leu Gly Leu 11o Ile ASh Ph@ Val Phe Ala Tyr Leu Leu Gln Set Glu 110 
476 GCA GAC CTG CTG GCT GOT CTG GGA CTC ATC ATC AAT TTT GTT TTT GCC TAC CTG CTT CAG TCA GAA 
m 
Ala Thr Lys Lou Val  Thr  Ile GIy LeU If@ Val A1a Ser Ph@ Set Ala Sot Val Cys Set Leu Leu 132 
542 OCt ACC AAG CTG GTC ACA ATT GGA CTC ATT GTC GCC TCT TTC TCT GCC TCT GTC TGC AGT TTG CTG 
Ala Ila Thr  Val Asp  Arg  Tyr Leu Set Leu Tyr Tyr  Ala Leu Thr Tyr His Set Gly Gin Asp Arg 154 
608 OCT ATC ACT GTG GAC CGC TAC CTC TCG CTG TAT TAC GCC CTG ACG TAC CAC TCC GGA GAG GAC COT 
IV 
His Leu Tyr  Leu Cys Mot  Lou Val M~H Lou Trp G17 Thr Sot Thr Cys Leu GI~ L@u Leu Leu Tyr 17~ 
674 CAC CTT TAC CTA TOT ATG CTA GTG ATG CTC TOG GGA ACT TCC ACC TGC CTG GGG CTG CTG CTG TAT 
Gly Lou GIu Lou PEo  Glu Gly Arg Val His Leu Gin Arg Gly Gln Thr L@u ThE Lys Ash Ash Ala 198 
740 GGG CTG GAA CTG CCT GAG GGA CGA GTC CAC CTG CAG CGT GOT CAG ACC GtC ACT AAG AAC AAC GCC 
V 
Ala If@ Leu Set I le Set Ph@ Leu Ph~ Met Ph~ Ala Lou Met Leu Gin Leu Tyr Zle Gin Ile Cys 220 
806 GCC ATT CTC TCC ATC TCC TTC CTC TTC ATG TTC GCA CTG ATG CTC CAA CTC TAC ATC CAG ATT TGT 
Lys If@ Val  Met Arg  His Ala His Gln Ii~ Ala Leu Gln His His Phe Leu Ala Thr Ser His Tyr 242 
87~ AAG ATT GTG ATG AGG CAC GCC CAT GAG ATA GCC GTG CAG CAC CAC TTC CTG OCT ACG TCG CAC TAC 
Val Thr ThE Arg Lys Gly Ile Set Thr Lou Ala Leu Ile Lsu Gly Thr Phe Ala Ala Cys Trp M@t 264 
938 GTG ACT ACC COG AAA GGG ATC ~CC ACC CTG OCT CTC ATC CTG GGG ACC TTT GCC GCC TGC TGG ATG 
VII 
Pro Phe Thr  Lou Tyr  set  Leu Iio Ala Asp Tyr Thr  Tyr Pro Set Ilo Tyr Thr Tyr Ala Thr Leu 286 
1004 CCT TTT ACC CTC TAT  TCC TTG ATC GCC GAT TAC ACC TAC CCC TCC ATC TAC ACC TAC GCC ACC CTC 
vn 
Lsu Pro Ala  Thr Tyr  AS~ Set lie If@ Asn Pro Val  If@ Tyr Ala Ph@ Arg Ash Gin Glu Ile Gln 308 
1070 CTG CCC qCC ~C~ T~.C ~AT TCC ATC ATC AAC CCT GTC ATA TAT OCT TTC AGA AAC CAA GAG ATC CAG 
Lys A1a Pro Leu Pro  His Lou Leu Trp Val ~is Pro  Stop 320 
1136 AAA GCC CCT CTG CCT CAT CTG CTG TOG GTG CAT CCC TAA CACGCTGTCCAGAGAGCACGCTCTCCCAGGGATGT 
1210 GTAG•AG•GTT•TcccCA•AGGA•GcTG••T•TAcTAAG•GAcCc•A•TG•••AGGGcAG••GGTGA•TT••TCcc•TTAAATT•TT  
1297 TGcA•TGGATcTCACAGGcAGAAG•AA•GATATcTTTTAGA•TAGTGTTGGCAGTGGAAATcATGTTAcCAGTGTTTTAAAAAACTc  
1384 AAcTT•T•GG•TTAG•ATTc•GTTGTTTGGTTTGGGAGTTAGGA•TTGTTTGTTTGTTTGTTTGTTTGGAGGGTGTAGTGG•A•CT•  
1471 ATGTGGC C GTAA~ATTATACACAAGTCTCAGGATTTTTAACCTAGACTTGAA~ATAAATCnGTTTTAAAG G AAAAAAAAA 
Fig. 1. eDNA and predicted amino acid sequence of the putative R334 receptor. Potcntial N-linked glycosylation sites in the NH=-terminal region 
(~), and phospho~lation sites in the COOH-tcrminal region ()) are indicated, The putative transmembrane domains I-VII are underlincd 
and are assigned on the basis of a Kyte and Doolittle [18] hydropathicity plot. The polyadenylation signal is underlined. 
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2.6. Eukaryotic e.,q~ression 
R334 was cloned into pcDNA 1 neo vector (Invitrogen) and transfec- 
ted using Lil.'cfcctin Reagent (BRL) into the 293 cell line. G418- 
selected (Oeneticin, Gibco: 800 ~'g/ml) transfectants were isolated and 
checked for integration and expression of pcDNAlneo R334 by PCR 
and Northern blot analysis of cellular mRNA.  Cells were maintained 
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in DMEM media containing 10% (v/v) heat inactivated foetal calf 
serum, glutamine (0.3 mg/ml), penicillin (100 IU/ml) and streptomycin 
(100 ttg/ml) and incubated at 37°C in 5% CO.,. cAMP was measured 
[9. I0] as were total inositol phosphates (IP I, I P2 and IP3) after extrac- 
tion and separation [I I]. Whole-cell current measurements in Xenopus 
oocytes injected with R334 mRNA transcripts were carried out using 
two-electrode voltage-clamp techniques [12]. 
3. RESULTS AND DISCUSSION 
PCR products generated from rat pituitary eDNA 
included a 400 bp band of PCR-amplified DNA which 
was purified by agarose gel electrophoresis and used to 
probe a rat pituitary eDNA library. Several indepen- 
dent cDNAs were isolated at low abundance and se- 
quence analysis of these clones showed them to consist 
of identical stretches of sequence. The most complete 
eDNA clone, R334, of 1552 bp, contained a region of 
open reading frame corresponding to a peptide of 320 
amino acids (Fig. l), possessing seven highly hydropho- 
bic regions of 20--25 amino acids. A search was per- 
formed on the OWL database for the protein sequence 
using the PROSRCH program of Coulson et al. [13] 
running on the DAP. This yielded a list of  matching 
proteins, of which the best-fitting 50 included 47 which 
were 13 protein-coupled receptors. None of these 
proteins were identical with R334, or sufficiently close 
in structure to suggest membership of a known sub- 
family. The deduced amino acid sequence of  R334 and 
alignment with 7 other members of the G protein- 
coupled receptor family is illustrated in Fig. 2. 
The R334 sequence contains potential N-linked gly- 
cosylation sites Ash 8 and Asn -'4 in the amino terminal 
region and potential phosphorylation sites, Thr :4., 
Thr z4s and Ser TM in the carboxyl-terminal region. The 
Asp residue in TM3, shown to be essential for ligand 
binding in the fl-AR receptor [14], is absent in R334 
(Fig. 2). Of all the cloned receptors aligned in Fig. 2, 
R334 contains the shortest third cytoplasmic loop. This 
loop has been shown to be important for G protein 
recognition [14]. R334 displays 22% homology across 
the TM domains with the cannabinoid receptor, 16% 
and 17% with rat substance P and substance K recep- 
tors, 17% with the human/~2 adrenergic receptor and 
18% with the 5HTIA receptor. The 3'-untranslated re- 
gion contains a polyadenylation signal and a poly(A) 
tract (Fig. I). 
The tissue distribution of R334 mRNA in rat tissues 
was examined. Northern blotting showed a faint hybri- 
dizing band greater than 7 kb in brain and testis (not 
shown). Because Northern analysis was found to be too 
insensitive to satisfactorily detect he low-level expres- 
sion of R334 mRNA in these tissues, PCR analysis of 
reverse-transcribed RNA prepared from pituitary, 
brain and peripheral tissues was carried out [16]. A 
PCR-amplified band exactly corresponding to the dis- 
tance between the two primers as predicted from the 
R334 sequence (355 bp) was observed in the pituitary 
gland, brain and testis RNA (Fig. 3). No signal was 
observed in any of the other tissues examined (see Fig. 
3). 
The localization and distribution of R334 mRNA in 
the pituitary gland and brain were studied by in situ 
hybridization. R334 mRNA was detected in pituitary 
tissue (Fig. 4A,B), in the piriform cortex of the brain 
(Fig. 4C,D) as well as in the lateral septal nuclei (not 
shown). Diffuse labelling of cells was seen in the ante- 
rior pituitary gland and posterior lobes (Fig. 4A), while 
in the brain, the signal was restricted to discrete areas 
only (Fig. 4C). Control sections probed with the sense 
riboprobe showed non-specific background hybridiza- 
tion only (Fig. 4B,D). 
We have investigated a number of possible ligands for 
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Fig. 3, PCR analysis of R334 transcript tissue distribution. PCR with 
primers corresponding to R334 was carried out in the presence of" 
[~:P]dCTP on cDNAs synthesized from rat tissue RNA. R~,34 cDNA 
was cmployed as a positive control. Labelled reaction pr~,du,~ts were 
electrophoresed on asequencing gel and autoradiographcd. From left 
to right', Lane i, t~o DNA; lane 2, R334 eDNA; lanes 3-12, RNA fr,,m 
testis, lung. ovary, pituitary, brain, kidney, liver, spleen, adrenal and 
hear t ,  
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Fig. 4. Autoradiographic detection of cells containing R334 mRNA in rat pituitary and brain tissue by in situ hybridization. Dark-field micrographs 
of emulsion dipped (A) pituitary ilorizontal sections (a, anterior; p, posterior), hybridized with R334 antisense riboprobe; (B) pituitary with sense 
riboprobe; (C) coronal sections through rat brain piriform cortex (pc) hybridized with antisense riboprobe; (D) sense riboprobe, 
this receptor.  Synthetic, capped RNA transcr ibed from 
R334 cDNA was injected into Xenopus laevis oocytes, 
along with RNA transcr ibed f rom the 5HT lc  receptor 
cDNA c lone [17] as a posit ive control.  33 di f ferent po- 
tential l igands were appl ied to the bath ing solution. 
A l though definite electrophysiological  responses to se- 
rotonin were  detected (current = 500-1000 nA), no sig- 
nificant response to any o f  the drugs was apparent .  
cAMP and  total inositol phosphate  assays were also 
per fo rmed on stable transfected cell lines expressing 
R334 mRNA fol lowing exposure to these drugs.  None 
o f  the substances tested st imulated cAMP product ion 
(or inhibited cAMP product ion  in forskol in-treated 
cells). Similarly, measurements  o f  total inositol  phos- 
phates showed no measurable  ffects (data not shown). 
A l though we were unable to identify the l igand for 
the R334 receptor,  the observed homologies  with 
known receptor  sequences and the characterist ics o f  the 
hydropath ic i ty  profi le all suggest strongly that this se- 
quence is that  of  a previously unknown receptor  belong- 
ing to the G prote in-coupled receptor  family. Further  
studies are required to demonst ra te  that this molecule 
functions as a biological ly active receptor. 
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